These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 11059786)

  • 21. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
    Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
    Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression.
    Mazure NM; Chen EY; Yeh P; Laderoute KR; Giaccia AJ
    Cancer Res; 1996 Aug; 56(15):3436-40. PubMed ID: 8758908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
    Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AMP-dependent protein kinase alpha 2 isoform promotes hypoxia-induced VEGF expression in human glioblastoma.
    Neurath KM; Keough MP; Mikkelsen T; Claffey KP
    Glia; 2006 May; 53(7):733-43. PubMed ID: 16518831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo.
    Kuroki M; Voest EE; Amano S; Beerepoot LV; Takashima S; Tolentino M; Kim RY; Rohan RM; Colby KA; Yeo KT; Adamis AP
    J Clin Invest; 1996 Oct; 98(7):1667-75. PubMed ID: 8833917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The farnesyltransferase inhibitor LB42708 suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signal pathways.
    Kim CK; Choi YK; Lee H; Ha KS; Won MH; Kwon YG; Kim YM
    Mol Pharmacol; 2010 Jul; 78(1):142-50. PubMed ID: 20406854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.
    Feldkamp MM; Lau N; Guha A
    Oncogene; 1999 Dec; 18(52):7514-26. PubMed ID: 10602510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation.
    Li M; Wang J; Ng SS; Chan CY; He ML; Yu F; Lai L; Shi C; Chen Y; Yew DT; Kung HF; Lin MC
    Cancer; 2009 Nov; 115(21):4959-72. PubMed ID: 19642173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.
    Rak J; Mitsuhashi Y; Bayko L; Filmus J; Shirasawa S; Sasazuki T; Kerbel RS
    Cancer Res; 1995 Oct; 55(20):4575-80. PubMed ID: 7553632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway.
    Clarke K; Smith K; Gullick WJ; Harris AL
    Br J Cancer; 2001 May; 84(10):1322-9. PubMed ID: 11355942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I.
    Akagi Y; Liu W; Zebrowski B; Xie K; Ellis LM
    Cancer Res; 1998 Sep; 58(17):4008-14. PubMed ID: 9731515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells.
    Chin K; Kurashima Y; Ogura T; Tajiri H; Yoshida S; Esumi H
    Oncogene; 1997 Jul; 15(4):437-42. PubMed ID: 9242380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
    Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
    Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of vascular endothelial growth factor expression after A(2A) adenosine receptor activation in PC12 pheochromocytoma cells.
    Olah ME; Roudabush FL
    J Pharmacol Exp Ther; 2000 Jun; 293(3):779-87. PubMed ID: 10869376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis.
    Yen L; You XL; Al Moustafa AE; Batist G; Hynes NE; Mader S; Meloche S; Alaoui-Jamali MA
    Oncogene; 2000 Jul; 19(31):3460-9. PubMed ID: 10918604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation.
    Mukhopadhyay D; Tsiokas L; Zhou XM; Foster D; Brugge JS; Sukhatme VP
    Nature; 1995 Jun; 375(6532):577-81. PubMed ID: 7540725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells.
    Suzuma K; Takagi H; Otani A; Honda Y
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):1028-35. PubMed ID: 9579483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner.
    Chakravarti A; Chakladar A; Delaney MA; Latham DE; Loeffler JS
    Cancer Res; 2002 Aug; 62(15):4307-15. PubMed ID: 12154034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice.
    Weissenberger J; Steinbach JP; Malin G; Spada S; Rülicke T; Aguzzi A
    Oncogene; 1997 May; 14(17):2005-13. PubMed ID: 9160879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory mechanism of vascular endothelial growth factor (VEGF) by bucillamine.
    Koyama S; Takagi H; Otani A; Oh H; Nishimura K; Honda Y
    Br J Pharmacol; 2002 Nov; 137(6):901-9. PubMed ID: 12411422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.